Literature DB >> 25904096

Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Shintaro Yamazaki1, Tadatoshi Takayama2, Tokio Higaki3, Masamichi Moriguchi3, Nao Yoshida3, Teruyuki Miyazaki3, Yoichi Teshima3.   

Abstract

BACKGROUND: To investigate the efficacy of the early administration of pancreatic enzymes combined with an elemental diet of branched-chain amino acids (BCAA) for nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy (PD).
METHODS: Data were obtained for 122 consecutive patients who underwent PD. High-titer pancrelipase and a BCAA-rich solution was administered via a feeding tube beginning on postoperative day (POD) 4 (PB group: n = 31). Ninety-one patients who underwent PD prior to this treatment were included as a control group (n = 91). The radiological changes in the liver and pancreatic parenchyma related to NAFLD before and after PD were assessed on CT, and trends in liver function and nutritional status were evaluated over the 180-day post-PD period.
RESULTS: Patient background factors, histopathology and operation-related variables were not significantly different between the two groups. Liver attenuation [56 HU (-13 to 73) vs. 61 (26 to 69), p = 0.015] and the liver-to-spleen attenuation ratio [1.12 (-0.38 to 1.48) vs. 1.24 (0.89 to 1.49), p = 0.018] were significantly decreased, and the pancreatic parenchyma was significantly thinner [17.9 mm (8.6-25.3) vs. 13.9 mm (2.5-23.2), p = 0.02] in the control group at 3 months after the operation. The alanine aminotransferase levels were also higher in the control group (p < 0.05, at POD 14, 30, 60 and 90), while the serum albumin (p < 0.05, at POD 30, 60 and 180) and total protein (p < 0.05, at POD 30, 60, 90 and 180) levels were significantly better in the PB group.
CONCLUSIONS: Early supplementation of high-titer pancrelipase combined with a BCAA-rich elemental diet reduces the risk of NAFLD after PD.

Entities:  

Keywords:  Branched-chain amino acids; Nonalcoholic fatty liver disease; Pancreaticoduodenectomy

Mesh:

Substances:

Year:  2015        PMID: 25904096     DOI: 10.1007/s00535-015-1077-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  31 in total

1.  Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Minako Nagai; Masayuki Sho; Sohei Satoi; Hideyoshi Toyokawa; Takahiro Akahori; Hiroaki Yanagimoto; Tomohisa Yamamoto; Satoshi Hirooka; So Yamaki; Shoichi Kinoshita; Satoshi Nishiwada; Naoya Ikeda; A-Hon Kwon; Yoshiyuki Nakajima
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-06-20       Impact factor: 7.027

2.  Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis.

Authors:  Shinji Togo; Kuniya Tanaka; Daisuke Morioka; Mitsutaka Sugita; Michio Ueda; Yasuhiko Miura; Toru Kubota; Yasuhiko Nagano; Kenichi Matsuo; Itaru Endo; Hitoshi Sekido; Hiroshi Shimada
Journal:  Nutrition       Date:  2005-04       Impact factor: 4.008

3.  Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahide Yokoyama; Gengo Kaneko; Naoto Horigome; Takahiro Yamaura; Tadanobu Nagaya; Michiharu Komatsu; Kenji Sano; Shin-Ichi Miyagawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-01-26       Impact factor: 7.527

4.  Reduced pancreatic parenchymal thickness indicates exocrine pancreatic insufficiency after pancreatoduodenectomy.

Authors:  Hiroyuki Nakamura; Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo; Hiroki Ohge; Taijiro Sueda
Journal:  J Surg Res       Date:  2010-04-18       Impact factor: 2.192

5.  Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients.

Authors:  Ken Shirabe; Masanori Yoshimatsu; Takashi Motomura; Kazuki Takeishi; Takeo Toshima; Jun Muto; Rumi Matono; Akinobu Taketomi; Hideaki Uchiyama; Yoshihiko Maehara
Journal:  Liver Transpl       Date:  2011-09       Impact factor: 5.799

6.  Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

Authors:  H J Andreyev; A R Norman; J Oates; D Cunningham
Journal:  Eur J Cancer       Date:  1998-03       Impact factor: 9.162

7.  Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency.

Authors:  Naoya Nakagawa; Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Naru Kondo; Hayato Sasaki; Keisuke Okano; Taijiro Sueda
Journal:  J Surg Oncol       Date:  2014-06-25       Impact factor: 3.454

8.  13C-labeled trioctanoin breath test for exocrine pancreatic function test in patients after pancreatoduodenectomy.

Authors:  H Kato; A Nakao; W Kishimoto; T Nonami; A Harada; T Hayakawa; H Takagi
Journal:  Am J Gastroenterol       Date:  1993-01       Impact factor: 10.864

9.  S-1 vs. gemcitabine as an adjuvant therapy after surgical resection for ductal adenocarcinoma of the pancreas.

Authors:  Takehiro Okabayashi; Yasuo Shima; Jun Iwata; Sojiro Morita; Tatsuaki Sumiyoshi; Akihito Kozuki; Teppei Tokumaru; Tatsuo Iiyama; Takuhiro Kosaki; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

10.  Long-term outcome after resection for chronic pancreatitis in 224 patients.

Authors:  Hartwig Riediger; Ulrich Adam; Eva Fischer; Tobias Keck; Frank Pfeffer; Ulrich T Hopt; Frank Makowiec
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

View more
  4 in total

1.  Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomy.

Authors:  Hirohisa Okabe; Yo-Ichi Yamashita; Risa Inoue; Shotaro Kinoshita; Rumi Itoyama; Toshihiko Yusa; Yosuke Nakao; Takanobu Yamao; Naoki Umezaki; Masayo Tsukamoto; Yuki Kitano; Tatsunori Miyata; Kota Arima; Hiromitsu Hayashi; Katsunori Imai; Akira Chikamoto; Hideo Baba
Journal:  Surg Today       Date:  2019-08-28       Impact factor: 2.549

2.  Clinical Outcome of Residual Liver Volume and Hepatic Steatosis After Right-Lobe Living-Donor Hepatectomy.

Authors:  Chia-En Hsieh; Kuo-Hua Lin; Ya-Lan Hsu; Chen-Te Chou; Chia-Bang Chen; Ping-Yi Lin; Chia-Cheng Lin; Yu-Ju Hung; Li-Chueh Weng; Yao-Li Chen
Journal:  Ann Transplant       Date:  2020-03-10       Impact factor: 1.530

Review 3.  Mechanisms of nonalcoholic fatty liver disease and implications for surgery.

Authors:  Ariel E Feldstein; Daniel Hartmann; Benedikt Kaufmann; Agustina Reca; Baocai Wang; Helmut Friess
Journal:  Langenbecks Arch Surg       Date:  2020-08-24       Impact factor: 3.445

4.  Effect of pancrelipase in preventing pancreatic dysfunction after pancreaticoduodenectomy.

Authors:  Yukio Asano; Akihiko Horiguchi; Masahiro Ito; Satoshi Arakawa; Shinpei Furuta; Masahiro Shimura; Chihiro Hayashi; Kenshiro Kamio; Toki Kawai; Hironobu Yasuoka; Takahiko Higashiguchi
Journal:  Fujita Med J       Date:  2019-04-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.